Catheter ablation of atrial fibrillation in the elderly: does the benefit outweigh the risk?

References

• Fuster V, Rydén LE, Cannom DS et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation – executive summary. J. Am. Coll. Cardiol. 48(4), 854–906 (2006).
   Google Scholar
• Go AS, Hylek EM, Phillips KA et al. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA 285(18), 2370–2375 (2001).
   PubMed Web of Science ®Google Scholar
• Furberg CD, Psaty BM, Manolio TA, Gardin JM, Smith VE, Rautaharju PM. Prevalence of atrial fibrillation in elderly subjects (the Cardiovascular Health Study). Am. J. Cardiol. 74(3), 236–241 (1994).
   PubMed Web of Science ®Google Scholar
• Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch. Intern. Med. 155(5), 469–473 (1995).
   PubMed Web of Science ®Google Scholar
• Haegeli LM, Duru F. Atrial fibrillation in the aging heart: pharmacological therapy and catheter ablation in the elderly. Future Cardiol. 7(3), 415–423 (2011).
   PubMedGoogle Scholar
• Fang MC, Chen J, Rich MW. Atrial fibrillation in the elderly. Am. J. Med. 120(6), 481–487 (2007).
   PubMed Web of Science ®Google Scholar
• Traub D, Daubert JP, McNitt S, Zareba W, Hall B. Catheter ablation of atrial fibrillation in the elderly: where do we stand? Cardiol. J. 16(2), 113–120 (2009).
   PubMedGoogle Scholar
• Lip GY, Kakar P, Watson T. Atrial fibrillation – the growing epidemic. Heart 93(5), 542–543 (2007).
   PubMed Web of Science ®Google Scholar
• Miyasaka Y, Barnes ME, Gersh BJ et al. Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation 114(2), 119–125 (2006).
   PubMed Web of Science ®Google Scholar
• Friberg J, Buch P, Scharling H, Gadsbphioll N, Jensen GB. Rising rates of hospital admissions for atrial fibrillation. Epidemiology 14(6), 666–672 (2003).
   PubMed Web of Science ®Google Scholar
• Berry C, Rae A, Taylor J, Brady AJ. Atrial fibrillation in the elderly. Br. J. Cardiol. 10(5), 373–378 (2003).
   Google Scholar
• Yamada T, Kay GN. Catheter ablation of atrial fibrillation in the elderly. Pacing Clin. Electrophysiol. 32(8), 1085–1091 (2009).
   PubMedGoogle Scholar
• Wongcharoen W, Chen YC, Chen YJ et al. Aging increases pulmonary veins arrhythmogenesis and susceptibility to calcium regulation agents. Heart Rhythm 4(10), 1338–1349 (2007).
   PubMedGoogle Scholar
• Le Heuzey JY, Paziaud O, Piot O et al. Cost of care distribution in atrial fibrillation patients: the COCAF study. Am. Heart J. 147(1), 121–126 (2004).
   PubMed Web of Science ®Google Scholar
• Coyne KS, Paramore C, Grandy S, Mercader M, Reynolds M, Zimetbaum P. Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States. Value Health 9(5), 348–356 (2006).
   PubMed Web of Science ®Google Scholar
• Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. Am. J. Med. 113(5), 359–364 (2002).
   PubMed Web of Science ®Google Scholar
• Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N. Engl. J. Med. 306(17), 1018–1022 (1982).
   PubMed Web of Science ®Google Scholar
• Rathore SS, Berger AK, Weinfurt KP et al. Acute myocardial infarction complicated by atrial fibrillation in the elderly: prevalence and outcomes. Circulation 101(9), 969–974 (2000).
   PubMed Web of Science ®Google Scholar
• Benjamin EJ, Wolf PA, D’Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 98(10), 946–952 (1998).
   PubMed Web of Science ®Google Scholar
• Ozcan C, Jahangir A, Friedman PA et al. Long-term survival after ablation of the atrioventricular node and implantation of a permanent pacemaker in patients with atrial fibrillation. N. Engl. J. Med. 344(14), 1043–1051 (2001).
   PubMed Web of Science ®Google Scholar
• Marinigh R, Lip GY, Fiotti N, Giansante C, Lane DA. Age as a risk factor for stroke in atrial fibrillation patients implications for thromboprophylaxis: Implications for thromboprophylaxis. J. Am. Coll. Cardiol. 56(11), 827–837 (2010).
   PubMed Web of Science ®Google Scholar
• Roy D, Talajic M, Nattel S et al.; Atrial Fibrillation and Congestive Heart Failure Investigators. Rhythm control versus rate control for atrial fibrillation and heart failure. N. Engl. J. Med. 358(25), 2667–2677 (2008).
   PubMed Web of Science ®Google Scholar
• Aronow WS. Management of the older person with atrial fibrillation. J. Gerontol. A Biol. Sci. Med. Sci. 57(6), M352–M363 (2002).
   Google Scholar
• Prystowsky EN. Assessment of rhythm and rate control in patients with atrial fibrillation. J. Cardiovasc. Electrophysiol. 17(Suppl. 2), S7–S10 (2006).
   Google Scholar
• Hurwitz JL. Atrial fibrillation treatment in the elderly: are we getting closer to an answer? J. Cardiovasc. Electrophysiol. 19(8), 812–814 (2008).
   PubMedGoogle Scholar
• Dayer M, Hardman SM. Special problems with antiarrhythmic drugs in the elderly: safety, tolerability, and efficacy. Am. J. Geriatr. Cardiol. 11(6), 370–375 (2002).
   PubMedGoogle Scholar
• Curtis AB, Rich MW. Atrial fibrillation in the elderly: mechanisms and management. Heart Rhythm 4(12), 1577–1579 (2007).
   PubMedGoogle Scholar
• Pappone C, Rosanio S, Augello G et al. Mortality, morbidity, and quality of life after circumferential pulmonary vein ablation for atrial fibrillation: outcomes from a controlled nonrandomized long-term study. J. Am. Coll. Cardiol. 42(2), 185–197 (2003).
   PubMed Web of Science ®Google Scholar
• Oral H, Pappone C, Chugh A et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N. Engl. J. Med. 354(9), 934–941 (2006).
   PubMed Web of Science ®Google Scholar
• Cappato R, Calkins H, Chen SA et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ. Arrhythm. Electrophysiol. 3(1), 32–38 (2010).
   PubMed Web of Science ®Google Scholar
• Wann LS, Curtis AB, January CT et al.; ACCF/AHA/HRS. 2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (Updating the 2006 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J. Am. Coll. Cardiol. 57(2), 223–242 (2011).
   PubMed Web of Science ®Google Scholar
• Bertaglia E, Tondo C, De Simone A et al. Does catheter ablation cure atrial fibrillation? Single-procedure outcome of drug-refractory atrial fibrillation ablation: a 6-year multicentre experience. Europace 12(2), 181–187 (2010).
   PubMed Web of Science ®Google Scholar
• Calkins H, Reynolds MR, Spector P et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ. Arrhythm. Electrophysiol. 2(4), 349–361 (2009).
   PubMed Web of Science ®Google Scholar
• Noheria A, Kumar A, Wylie JV Jr, Josephson ME. Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: a systematic review. Arch. Intern. Med. 168(6), 581–586 (2008).
   PubMedGoogle Scholar
• Oral H, Scharf C, Chugh A et al. Catheter ablation for paroxysmal atrial fibrillation: segmental pulmonary vein ostial ablation versus left atrial ablation. Circulation 108(19), 2355–2360 (2003).
   PubMed Web of Science ®Google Scholar
• Pappone C, Rosanio S, Oreto G et al. Circumferential radiofrequency ablation of pulmonary vein ostia: A new anatomic approach for curing atrial fibrillation. Circulation 102(21), 2619–2628 (2000).
   PubMed Web of Science ®Google Scholar
• Pappone C, Augello G, Sala S et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF Study. J. Am. Coll. Cardiol. 48(11), 2340–2347 (2006).
   PubMed Web of Science ®Google Scholar
• Piccini JP, Lopes RD, Kong MH, Hasselblad V, Jackson K, Al-Khatib SM. Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: a meta-analysis of randomized, controlled trials. Circ. Arrhythm. Electrophysiol. 2(6), 626–633 (2009).
   PubMed Web of Science ®Google Scholar
• Reynolds MR, Zimetbaum P, Josephson ME, Ellis E, Danilov T, Cohen DJ. Cost-effectiveness of radiofrequency catheter ablation compared with antiarrhythmic drug therapy for paroxysmal atrial fibrillation. Circ. Arrhythm. Electrophysiol. 2(4), 362–369 (2009).
   PubMed Web of Science ®Google Scholar
• Stabile G, Bertaglia E, Senatore G et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (Catheter Ablation For The Cure Of Atrial Fibrillation Study). Eur. Heart J. 27(2), 216–221 (2006).
   PubMed Web of Science ®Google Scholar
• Terasawa T, Balk EM, Chung M et al. Systematic review: comparative effectiveness of radiofrequency catheter ablation for atrial fibrillation. Ann. Intern. Med. 151(3), 191–202 (2009).
   PubMed Web of Science ®Google Scholar
• Wazni OM, Marrouche NF, Martin DO et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 293(21), 2634–2640 (2005).
   PubMed Web of Science ®Google Scholar
• Wilber DJ, Pappone C, Neuzil P et al.; ThermoCool AF Trial Investigators. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA 303(4), 333–340 (2010).
   PubMed Web of Science ®Google Scholar
• Nademanee K, Schwab MC, Kosar EM et al. Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation. J. Am. Coll. Cardiol. 51(8), 843–849 (2008).
   PubMed Web of Science ®Google Scholar
• Jaïs P, Cauchemez B, Macle L et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation 118(24), 2498–2505 (2008).
   PubMed Web of Science ®Google Scholar
• MacDonald MR, Connelly DT, Hawkins NM et al. Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial. Heart 97(9), 740–747 (2011).
   PubMed Web of Science ®Google Scholar
• Packer DL, Lee KL, Mark DB et al. Catheter ablation vs. antiarrhythmic drug therapy for atrial fibrillation: Results of the CABANA pilot study. ACC Scientific Sessions, Atlanta, GA, USA, 15 March 2010.
   Google Scholar
• Hsieh MH, Tai CT, Lee SH et al. Catheter ablation of atrial fibrillation versus atrioventricular junction ablation plus pacing therapy for elderly patients with medically refractory paroxysmal atrial fibrillation. J. Cardiovasc. Electrophysiol. 16(5), 457–461 (2005).
   PubMed Web of Science ®Google Scholar
• Corrado A, Patel D, Riedlbauchova L et al. Efficacy, safety, and outcome of atrial fibrillation ablation in septuagenarians. J. Cardiovasc. Electrophysiol. 19(8), 807–811 (2008).
   PubMedGoogle Scholar
• Zado E, Callans DJ, Riley M et al. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in the elderly. J. Cardiovasc. Electrophysiol. 19(6), 621–626 (2008).
   PubMed Web of Science ®Google Scholar
• Leong-Sit P, Zado E, Callans DJ et al. Efficacy and risk of atrial fibrillation ablation before 45 years of age. Circ. Arrhythm. Electrophysiol. 3(5), 452–457 (2010).
   PubMed Web of Science ®Google Scholar
• Tuan TC, Chang SL, Tsao HM et al. The impact of age on the electroanatomical characteristics and outcome of catheter ablation in patients with atrial fibrillation. J. Cardiovasc. Electrophysiol. 21(9), 966–972 (2010).
   PubMedGoogle Scholar
• Bunch TJ, Weiss JP, Crandall BG et al. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in octogenarians. Pacing Clin. Electrophysiol. 33(2), 146–152 (2010).
   PubMed Web of Science ®Google Scholar
• Santangeli P, Di Biase L, Mohanty P et al. Catheter ablation of atrial fibrillation in octogenarians: safety and outcomes. J. Cardiovasc. Electrophysiol. 23(7), 687–693 (2012).
   PubMed Web of Science ®Google Scholar
• Ellis ER, Culler SD, Simon AW, Reynolds MR. Trends in utilization and complications of catheter ablation for atrial fibrillation in Medicare beneficiaries. Heart Rhythm 6(9), 1267–1273 (2009).
   PubMed Web of Science ®Google Scholar
• Lee G, Sparks PB, Morton JB et al. Low risk of major complications associated with pulmonary vein antral isolation for atrial fibrillation: results of 500 consecutive ablation procedures in patients with low prevalence of structural heart disease from a single center. J. Cardiovasc. Electrophysiol. 22(2), 163–168 (2011).
   PubMed Web of Science ®Google Scholar
• Menke J, Lüthje L, Kastrup A, Larsen J. Thromboembolism in atrial fibrillation. Am. J. Cardiol. 105(4), 502–510 (2010).
   PubMed Web of Science ®Google Scholar
• Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 22(8), 983–988 (1991).
   PubMed Web of Science ®Google Scholar
• Lip GY. Does atrial fibrillation confer a hypercoagulable state? Lancet 346(8986), 1313–1314 (1995).
   PubMed Web of Science ®Google Scholar
• Oral H, Chugh A, Ozaydin M et al. Risk of thromboembolic events after percutaneous left atrial radiofrequency ablation of atrial fibrillation. Circulation 114(8), 759–765 (2006).
   PubMed Web of Science ®Google Scholar
• Guiot A, Jongnarangsin K, Chugh A et al. Anticoagulant therapy and risk of cerebrovascular events after catheter ablation of atrial fibrillation in the elderly. J. Cardiovasc. Electrophysiol. 23(1), 36–43 (2012).
   PubMedGoogle Scholar
• Holmes DR, Reddy VY, Turi ZG et al.; PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet 374(9689), 534–542 (2009).
   PubMed Web of Science ®Google Scholar
• Andrade JG, Khairy P, Guerra PG et al. Efficacy and safety of cryoballoon ablation for atrial fibrillation: a systematic review of published studies. Heart Rhythm 8(9), 1444–1451 (2011).
   PubMed Web of Science ®Google Scholar